Pregabalin Capsule
Product Images NDC 80425-0129
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig 10
Fig 11
Fig 12
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
This is a study report showing different dosages of a medication (ranging from 50mg/day to 600mg/day) and a placebo were administered to participants in three different studies (E1, E2, E3). The text includes numerical results, such as the percentage of participants experiencing adverse events, and mentions that certain dosages were statistically significant compared to the placebo.*
Fig 7
Fig 9
This appears to be a chart or table displaying the percentage of patients who experienced improvement in pain levels from their baseline when taking different doses of pregabalin, a medication used to treat nerve pain. The chart shows that the greatest improvement was seen at a daily dose of 600mg (labeled as "100%"), with lower levels of improvement seen at daily doses of 450mg, 300mg, and placebo.*
Formula
Pregabalin 300mg Cap Qty 90 Ndc 80425 0129
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.